Search

everythinglearnresearchcommunity

for

Search:↓

A woman with CCCA has hair loss due to factors like straighteners and tight hairstyles, and treatments include steroids and avoiding certain hair products.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

L'Oréal's research and workshops have advanced understanding and tailored cosmetics for African hair and skin.

TikTok can educate about alopecia, but more accurate content from medical professionals is needed.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Hesperidin may help reduce hair loss by protecting hair follicles.

Rosemary shows promise in treating alopecia, similar to minoxidil, but more research is needed.

Xtressé™ gummies may help increase hair growth in women, especially in early hair loss stages.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

ChatGPT is more accurate at diagnosing hair disorders in lighter skin tones than darker ones.

The condition is harmless, doesn't worsen, and needs no invasive treatment.

COVID-19 may trigger hair loss in some people.

Minoxidil may help with hair regrowth and disease stabilization in scarring alopecia, but side effects vary, needing more research for consistent safety and effectiveness.

The document concludes that more local research on African skin and hair is needed despite increased scientific output from Sub-Saharan Africa.

Biopsies matched initial diagnoses in 76.6% of black women with alopecia and led to treatment changes in 44% of cases.

Dermatologists need better training on Black hair to improve care and outcomes.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

The goal is to create a tool for patients to report their experiences with various hair and scalp disorders.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

The authors suggest a method for hair transplantation in fibrosing alopecia pattern distribution to improve treatment outcomes and cover bald areas.

Photobiomodulation therapy may help treat hair loss in people with darker skin, but more research is needed.

Hair follicle bumps with stem cells might contribute to permanent hair loss by getting disconnected due to scarring.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.